Related by context. All words. (Click for frequent words.) 74 azacytidine 73 CIMZIA ™ 73 TNF α 72 IL 1ß 72 interleukin IL 72 CIMZIA TM 71 GHRH 71 IFN gamma 71 mg kg dose 71 IFN beta 71 IFN alpha 71 relapsed MM 71 interferon γ 71 intratumoral injection 70 tumor xenograft models 70 DAPT 70 teriflunomide 70 ritonavir boosted 70 decitabine 70 Randomized Phase 70 interferon IFN 70 μmol L 69 Bortezomib 69 TIMP 1 69 Dasatinib 69 TNFalpha 69 muscarinic 69 daunorubicin 69 Traficet EN 69 nucleoside analog 69 PEG IFN 69 chlorambucil 69 FOLFIRI 69 EGFr 69 5HT 69 Pemetrexed 69 pegylated liposomal doxorubicin 69 Fulvestrant 69 ULORIC 69 ara C 69 PegIFN 69 mRCC 69 olmesartan 68 mycophenolate mofetil 68 idarubicin 68 serum HBV DNA 68 Natalizumab 68 TGF beta1 68 MGd 68 dose dependently 68 PSMA ADC 68 Decitabine 68 oblimersen 68 PegIFN RBV 68 μg ml 68 5alpha reductase 68 HCV replicon 68 CsA 68 TPV r 68 liposomal formulation 68 TMC# r 68 monocyte chemotactic protein 68 uM 68 Gleevec resistant 68 FOLPI 68 interferon alfa 68 APTIVUS r 68 isoenzyme 68 Xanafide 68 mRNA expression 68 Interferon gamma 68 HBeAg positive 68 glycogen synthase kinase 68 intratumoral 68 Interferon alfa 68 IFN γ 68 VEGF receptor 68 transgene expression 68 vitro cytotoxicity 68 ug kg 68 intravenous dosing 68 5FU 68 ENMD # 68 HIV RNA 68 lopinavir r 68 flavopiridol 68 gefitinib Iressa 68 ERalpha 68 Fludara 68 peripheral blood mononuclear 68 favorable pharmacokinetic profile 68 inducible nitric oxide synthase 68 comparator arm 68 beta 1a 68 interferon α 68 pan HDAC inhibitor 67 lymphocyte counts 67 Granulocyte Colony Stimulating Factor 67 cytokine interleukin 67 hepatoma 67 low dose cytarabine 67 prucalopride 67 mineralocorticoid receptor 67 CCX# 67 Aflibercept 67 receptor inhibitor 67 subcutaneously administered 67 LEXIVA r 67 fosbretabulin 67 receptor blocker 67 P selectin 67 atazanavir ritonavir 67 Androgen Receptor 67 5-FU/LV 67 Erlotinib 67 pomalidomide 67 TRAIL R2 67 posaconazole 67 cis retinoic acid 67 TRAIL R1 67 gemcitabine cisplatin 67 iNOS 67 Tumor Necrosis Factor 67 CD4 + CD# 67 EGFR HER2 67 Interferon Alfa 67 HDACi 67 CIMZIA TM certolizumab pegol 67 parathyroid hormone PTH 67 riociguat 67 Vidofludimus 67 IL 1beta 67 pegylated interferon alpha 67 Immunohistochemical analysis 67 rhIL 7 67 elotuzumab 67 5 Fluorouracil 67 DFMO 67 HGS ETR2 67 Epidermal Growth Factor Receptor 67 MEK1 67 IL #E 67 lactate dehydrogenase LDH 67 Nilotinib 67 VEGFR2 67 tocilizumab 67 imetelstat 67 HepG2 cells 67 CDK inhibitor 67 pathophysiological effects 67 selective modulator 67 ^ sup #m 67 HBeAg seroconversion 67 clodronate 67 Aptivus ® 67 doxorubicin cyclophosphamide 67 Fludarabine 67 Akt activation 67 AZT zidovudine Retrovir 67 Peginterferon 67 HIF 1a 67 Aurora kinase 67 viral kinetics 67 interleukin IL -# 67 KRAS wild 67 5 hydroxytryptamine 67 xenograft models 67 CLL SLL 67 administered subcutaneously 67 rFSH 67 anti inflammatory cytokine 66 fulvestrant 66 octreotide LAR 66 etoposide 66 ACZ# 66 galiximab 66 colorectal carcinoma 66 VELCADE melphalan 66 4mg/kg 66 azacitidine 66 Pegylated Interferon 66 divalproex sodium 66 sunitinib malate 66 hENT1 66 fluvastatin 66 T#I [002] 66 generation antisense inhibitor 66 Pharmacokinetics PK 66 Antitumor Activity 66 adriamycin 66 alfa 2a 66 sodium glucose cotransporter 66 miR #a [002] 66 ERK1 2 66 Vectibix monotherapy 66 somatostatin analog 66 Tipranavir 66 serum urate 66 log# copies mL 66 Angiotensin converting enzyme 66 imatinib therapy 66 Trastuzumab 66 leukocyte count 66 abacavir lamivudine 66 HCV RESPOND 2 66 ancrod 66 PEG interferon 66 hA# 66 gemcitabine carboplatin 66 sipuleucel T 66 apolipoprotein B 66 ribavirin RBV 66 Sym# 66 tipranavir r 66 effector function 66 Peg IFN 66 anti CD3 66 adrenoceptor 66 sorafenib Nexavar 66 Cardiotoxicity 66 tacrolimus ointment 66 5 HT2C receptor 66 alkylating agent 66 cinacalcet 66 colon carcinoma 66 demonstrated antitumor activity 66 HCV SPRINT 66 Lenalidomide 66 FOLFOX4 66 immunoreactivity 66 ceftazidime 66 dacarbazine 66 lumbar spine BMD 66 Castration Resistant Prostate Cancer 66 mapatumumab 66 fosamprenavir 66 IGFBP 66 Flu Cy 66 rhIGFBP 3 66 irbesartan 66 YONDELIS 66 Degarelix 66 tumor necrosis 66 t# c# CLA 66 nab paclitaxel 66 Nucleoside 66 insulin detemir 66 unfractionated heparin UFH 66 replicon 66 VEGFR1 66 vWF 66 docetaxel chemotherapy 66 timolol 66 c MET 66 isoproterenol 66 somatostatin 66 targeting CD# 66 crizotinib PF # 66 goserelin 66 inotropic 66 APTIVUS 66 CHOP chemotherapy 66 Lenocta 66 follicular lymphomas 66 achieved CCyR 66 1α 66 carboplatin paclitaxel 66 leukotriene 66 Omacetaxine mepesuccinate 66 Elitek 66 CR nPR 66 partial remissions 66 AEGR 66 genotypic resistance 66 papillary RCC 66 antiproliferative activity 66 trabectedin 66 mg TID 66 zoledronate 66 LPS induced 66 leukemia AML 66 nadolol 66 cMET 66 paricalcitol 66 nelfinavir 66 lispro 66 Parathyroid Hormone 66 LHRH agonist 66 HBsAg 66 erlotinib Tarceva ® 65 ACE Inhibitor 65 CTGF 65 oral rivaroxaban 65 SCH # 65 evaluating tivozanib 65 tumorigenicity 65 HT 1A 65 GW# [003] 65 CD# antibody [001] 65 gemcitabine Gemzar 65 pDC 65 cEVR 65 activin 65 Eg5 65 Receptor Antagonists 65 CR CRu 65 6 mercaptopurine 65 melphalan prednisone 65 pharmacokinetic interactions 65 FOLFOX6 65 antiproliferative effects 65 PDGFR 65 Sipuleucel T 65 tyrosine phosphorylation 65 cytokine signaling 65 mecamylamine 65 ovarian carcinoma 65 IGFBP 3 65 lymphocytosis 65 virological response 65 antitumor effects 65 Doxil ® 65 Akt phosphorylation 65 antitumor efficacy 65 retapamulin 65 antiapoptotic 65 potent inhibition 65 seliciclib 65 CRp 65 K ras mutations 65 lactate dehydrogenase 65 Interferon Beta 65 tipranavir 65 Epratuzumab 65 partial agonist 65 PC3 cells 65 TGF β 65 PEGylated Fab fragment 65 TNFa 65 hypoxia inducible factor 65 Pegylated Liposomal Doxorubicin 65 serum cortisol 65 Sgk1 65 ON #.Na 65 thalidomide Thalomid 65 Interferon beta 65 plasma uric acid 65 CDK4 65 bFGF 65 antiangiogenic therapy 65 miR #a [001] 65 vinca alkaloid 65 temsirolimus 65 Multiple Myeloma MM 65 Galectin 65 CANCIDAS 65 Anti Tumor Activity 65 Clusterin 65 sUA 65 darunavir ritonavir 65 genotype 1a 65 SVR# 65 eNOS 65 carcinoembryonic antigen 65 interleukin IL -6 65 TMC# C# 65 paclitaxel Taxol 65 TFPI 65 eIF4E 65 Omacetaxine 65 corticosteroid dose 65 β2 65 selective agonist 65 adecatumumab 65 PBMCs 65 tubulin polymerization 65 severe neutropenia 65 talabostat 65 mutated KRAS 65 Tubulin 65 receptor tyrosine kinase inhibitor 65 antiandrogen 65 dimeglumine 65 boosted protease inhibitor 65 metaglidasen 65 AVOREN 65 TACE 65 plus ribavirin 65 RRM1 65 Amrubicin 65 busulfan 65 immunostaining 65 TNF IL 65 cytokeratin 65 Monotherapy 65 AST ALT 65 antisense oligonucleotide 65 FLT3 65 hTERT 65 microglial activation 65 lanthanum carbonate 65 glatiramer acetate 65 alpha 2a 65 colorectal carcinomas 65 5 HT2A 65 sitaxsentan 65 neointimal hyperplasia 65 chemokine receptor 65 vidofludimus 65 Aurora Kinase 65 Oral Fingolimod 65 rhEPO 65 cytokines IL 65 protein tyrosine phosphatase 65 N methyl 65 taxane chemotherapy 65 glycosylated hemoglobin HbA1c 65 MAGE A3 ASCI 65 Pertuzumab 65 idraparinux 65 #HT#A 65 Pioglitazone 65 NXL# 65 M1 muscarinic 65 Supplemental Figure 65 cytostatic 65 Linagliptin 65 Recombinant Human 65 interferon alfa 2b 65 TPMT 65 oral diclofenac 65 epoetin alpha 65 estramustine 65 cilengitide 65 angiopoietin 65 steroid dexamethasone 65 bosentan 65 TLR antagonist 65 PEGPH# 65 INCB# [001] 65 constitutively active 65 NPH insulin 65 certolizumab 65 adalimumab Humira 65 trastuzumab Herceptin ® 65 LNCaP cells 65 cytokine IL 65 factor Xa 65 solithromycin 65 IFN g 65 ERK activation 65 ATL# [001] 65 Peginterferon Alfa 2a 65 orally administered inhibitor 65 verteporfin 65 Enzastaurin 65 Median PFS 65 mcg kg 65 ELACYT 65 pharmacodynamic parameters 65 E#F# 65 erythropoietic 65 prednisone prednisolone 65 CCR9 65 Hycamtin ® 65 active comparator 65 plus prednisone 65 serum phosphate 64 salmeterol fluticasone 64 AKT inhibitor 64 efavirenz EFV 64 visilizumab 64 rapid virologic response 64 pDCs 64 Lp PLA 2 64 Telmisartan 64 alteplase 64 elastase 64 depsipeptide 64 pegylated interferon alfa 2a 64 FOLFOX 64 thyrotropin 64 Vidaza azacitidine 64 Tyrosine Kinase Inhibitor 64 EGFR receptor 64 sunitinib 64 tolvaptan 64 immunomodulator 64 chloride secretion 64 Copegus ribavirin 64 regulated kinase 64 Prolongs Survival 64 docetaxel Taxotere ® 64 glutamyl 64 desvenlafaxine succinate 64 LY# [002] 64 canakinumab 64 ORMD 64 Ziprasidone 64 bendamustine 64 oral allopurinol 64 mg QD 64 Irinotecan 64 ongoing Phase 1b 64 CTAP# Capsules 64 biologic DMARD 64 metastatic RCC 64 mg/m2/day 64 GSK# [001] 64 piperacillin tazobactam 64 Bezielle 64 imatinib resistant 64 8mg/kg 64 serum calcium levels 64 bleomycin 64 Vandetanib 64 adipogenic 64 biochemical relapse 64 Bosentan 64 mcg BID 64 sorafenib Nexavar ® 64 methionine aminopeptidase 64 Metastatic Renal Cell Carcinoma 64 alanine aminotransferase ALT 64 KRAS mutations 64 tipifarnib 64 antiangiogenic 64 trans retinoic acid 64 antitumor activity 64 neurologic progression 64 F FDG PET 64 plasma renin activity 64 angiotensin receptor blocker ARB 64 EBMT criteria 64 Interferon alpha 64 #mg BID [003] 64 antiarrhythmic 64 Bevacizumab 64 pharmacokinetic PK profile 64 nutlin 3a 64 Androxal TM 64 menadione 64 nodular partial response 64 milatuzumab 64 IFN ß 64 Blinatumomab 64 oral JAK1 64 oral prodrug 64 REYATAZ r 64 EURIDIS 64 mg/m2 dose 64 Voreloxin 64 rosuvastatin #mg 64 pro apoptotic 64 Pharmacodynamic 64 comparator PI r 64 BENICAR HCT 64 tarenflurbil 64 annexin V 64 Neulasta ® 64 heparanase 64 adjunctive placebo 64 cells uL 64 thyroglobulin 64 SGLT 64 deacetylation 64 novel VDA molecule 64 Secretase 64 Initiated Phase 64 resected pancreatic cancer 64 Protease Inhibitors 64 Ceplene/IL-2 64 GnRH agonist 64 beta2 64 pharmacokinetic characteristics 64 SPRYCEL ® 64 Capecitabine 64 cetuximab Erbitux R 64 virologic response 64 microg 64 p# biomarker 64 MDR1 64 Cyclooxygenase 64 epoetin beta 64 PKC# 64 CYT# potent vascular disrupting 64 octreotide acetate 64 metastatic renal cell carcinoma 64 Azacitidine 64 beta1 64 NMDA antagonists 64 Antiviral Activity 64 CD#b 64 antithymocyte globulin 64 polymerase inhibitor 64 raltegravir 64 cell adhesion molecule 64 p = #.# [003] 64 coadministration 64 CD3 + 64 VAPRISOL 64 HuLuc# 64 serum phosphorous 64 HBeAg negative patients 64 protein tyrosine phosphatase 1B 64 Cyclooxygenase 2 64 endothelial nitric oxide synthase 64 μg kg 64 transfected cells 64 IFN β 64 S#A# [002] 64 LHRH agonists 64 MMP9 64 Glufosfamide 64 Temsirolimus 64 erlotinib Tarceva 64 MabCampath 64 pT3 64 lipoxygenase 64 plus dexamethasone 64 selective antagonist 64 Pgp 64 annexin 64 topotecan 64 5 lipoxygenase 64 recurrent GBM 64 db db mice 64 CBLC# 64 treatment naive genotype 64 Taxotere ® 64 DNA intercalator 64 mCRC patients 64 Teriflunomide 64 Aplidin 64 MEK inhibitor 64 biliary tract cancer 64 tolterodine 64 mmol kg 64 lenalidomide dexamethasone 64 IFN alfa 64 EGF receptor 64 #mg/day [002] 64 Pivotal Phase 64 murine 64 ascending dose 64 N acetyl 64 Pegasys ® 64 mediated inhibition 64 TGFβ 64 DCCR 64 undetectable HBV DNA 64 alpha1 64 exendin 4 64 EndoTAG TM -1 64 CorVue ™ 64 nucleoside 64 AT1R 64 LRAT 64 gonadotrophin releasing hormone GnRH 64 Mg Uk 64 Aplidin R 64 IL #p# 64 argatroban 64 calcitriol 64 dexamethasone Decadron 64 urocortin 2 64 Aliskiren 64 TGF ß 64 E1 INT TM 64 anti leukemic 64 antidiabetic 64 μg dose 64 ARB telmisartan 64 dosage regimens 64 axitinib 64 cancer mCRC 64 CA4P 64 caveolin 1 64 ACC2 64 bezafibrate 64 JAK2 V#F 64 IL 1β 64 Lubiprostone 64 brivaracetam 64 Navelbine 64 anti androgen 64 natriuretic peptide 64 ErbB2 positive 64 pg ml 64 Immunosuppression 64 systemic bioavailability 64 ritonavir boosted atazanavir 64 Micardis ® 64 #β estradiol 64 refractory AML 64 telaprevir dosed 64 somatostatin analogue 64 Telintra 64 PRECiSE 64 thymalfasin 64 IU ml 64 CCR2 64 urothelial carcinoma 64 Monocyte 64 gemcitabine Gemzar ® 64 TRAIL induced apoptosis 64 CALGB # [002] 64 experimental autoimmune encephalomyelitis 64 antiviral potency 64 VIAject ™ 64 EGFR tyrosine kinase inhibitors 64 microgram kg 64 ß2 64 refractory NSCLC 64 matrix metalloproteinase 64 IL6 64 Mg Usa 64 oral FTY# 64 Fenretinide 64 plasma pharmacokinetics 64 ISIS # 64 selective inhibition 64 CYT# QbG# 64 ACTEMRA TM 64 interferon gamma 1b 64 inflammatory cytokine 64 alpha#beta# integrin 64 antibody titer 64 cisplatin resistant 64 RANTES 64 Pharmacokinetic parameters 64 Antitumor 64 Kahalalide F 64 peginterferon alpha 2a 64 pertuzumab 64 corticosteroid dexamethasone 64 serum HCV RNA 64 RE LY ® 64 prostate carcinoma 64 Janus kinase 64 Catenin 64 multicenter randomized controlled 63 GRN#L 63 HER2 overexpression 63 Leydig cell 63 pharmacodynamic profile 63 HDAC Inhibitor 63 GAMMAGARD 63 ibandronate 63 cleavable linker 63 antitumor 63 GPx 63 huN# DM1 63 MAb 63 pharmacodynamic PD 63 CTLs 63 muscarinic receptor 63 ALT elevation 63 induces apoptosis 63 Symadex 63 CD# + [001] 63 TIMP 63 nitrotyrosine 63 lumbar spine bone 63 BRIM2 63 HER2/neu 63 ALB # 63 glucagon receptor 63 imatinib Gleevec 63 peginterferon 63 receptor monoclonal antibody 63 tipranavir ritonavir 63 Gemcitabine 63 alefacept 63 intercellular adhesion molecule 63 log# IU mL 63 CYP #D# 63 muscarinic receptors 63 eosinophilic asthma 63 dasatinib Sprycel 63 Immunomodulatory 63 haematologic 63 Dapagliflozin 63 dose cytarabine 63 MET amplification 63 mg BID 63 beta2 agonist 63 lumiliximab 63 gefitinib 63 Bosutinib 63 mitoxantrone 63 biotinylated 63 Imprime PGG 63 BARACLUDE ® 63 bortezomib 63 mitogenic 63 inhibitor RG# 63 LymphoStat B belimumab 63 insulin sensitizing 63 antiretroviral naive 63 PEDF 63 E selectin 63 EZN 63 immune modulator 63 CCyR 63 pheochromocytoma 63 PI3K inhibitor 63 monocyte chemoattractant protein 63 daily subcutaneous injections 63 nicardipine 63 HER2 expression 63 XELOX 63 BEACOPP 63 iniparib 63 cytoprotective 63 QTc prolongation 63 plus DOXIL 63 Gleevec imatinib mesylate 63 thrombin receptor 63 Virulizin ® 63 PEG SN# 63 immunoglobulin G 63 eplerenone 63 tenofovir emtricitabine 63 NK1 63 icatibant 63 iodixanol 63 Meets Primary Endpoint 63 familial amyloidotic polyneuropathy FAP 63 HER2 receptor 63 nutlin 63 vasoactive 63 Vfend 63 bioavailable testosterone 63 azilsartan medoxomil 63 PREZISTA ritonavir 63 BAY #-# 63 ZD# [001] 63 Kinoid 63 darbepoetin alfa 63 mg qd 63 pyrazinamide 63 p#Kip# 63 CCX# B 63 Tasimelteon 63 orally bioavailable 63 #mg BID [001] 63 bicalutamide 63 nucleoside analogue 63 Thrombin 63 Pharmacokinetic Study 63 endothelin receptor 63 histone deacetylase HDAC inhibitor 63 pegylated 63 TNFα 63 Double Blind Randomized 63 Azedra 63 assessing T DM1 63 colesevelam HCl 63 TNF antagonist 63 prostate cancer AIPC 63 L PPDS 63 FluCAM 63 1beta 63 neutrophil counts 63 dapagliflozin plus 63 rotigotine 63 Mutational 63 TLR2 63 Cytochrome P# 63 Darunavir 63 plasma HCV RNA 63 DOXIL 63 GLP1 63 Etanercept 63 TOP2A 63 Epirubicin 63 CaPre TM 63 CD# monoclonal antibody 63 cyclophosphamide methotrexate 63 tumor regressions 63 Ecallantide 63 apremilast 63 budesonide formoterol 63 bronchoalveolar lavage fluid 63 -#.# log# 63 dose cohort 63 macroalbuminuria 63 evaluable subjects 63 Solorel TM 63 mTOR inhibitors 63 Xelox 63 TGF β1 63 mg BID dose 63 fluoropyrimidine 63 pegylated interferon alfa 2b 63 tigecycline 63 hepatic insulin sensitivity 63 metastatic malignant 63 recurrent glioblastoma multiforme 63 Denufosol 63 HGS ETR1 63 Platinol 63 multicenter randomized placebo controlled 63 Folfox 63 rilonacept 63 ritonavir boosted lopinavir 63 ABCB1 63 saline placebo 63 antimuscarinic 63 triiodothyronine 63 HBeAg negative 63 trabedersen 63 eotaxin 63 serum concentrations 63 PSN# [002] 63 HBV DNA 63 Angiotensin Converting Enzyme 63 extracellular signal 63 ALGRX 63 vesicular monoamine transporter 63 GOUT 63 QT QTc 63 Epoetin Alfa 63 concurrent chemoradiation 63 rHuPH# 63 hepatic enzymes 63 Cyclosporine 63 HGPIN 63 FUS1 63 caspofungin 63 complement inhibitor eculizumab 63 ZOLINZA 63 colony stimulating factor 63 culture supernatants 63 endoscopic remission 63 CD# CD# 63 Antiviral Therapy 63 bortezomib refractory 63 Peg riba 63 LAF# 63 humanized anti 63 p# mitogen activated 63 cyclooxygenase 63 Inhalation Solution 63 EndoTAGTM 1 63 liver histology 63 metastatic neuroendocrine tumors 63 adenosine diphosphate ADP 63 NFkB 63 doxorubicin docetaxel 63 trastuzumab Herceptin R 63 oral antidiabetic 63 gamma secretase inhibitor 63 mcg albinterferon alfa 2b 63 baseline LDH 63 potent anti angiogenic 63 log# reduction 63 cytidine 63 fluticasone furoate 63 induced apoptosis 63 nucleotide analog 63 PDGF B 63 HSP# inhibitor 63 S/GSK# 63 adalimumab 63 Raltegravir 63 IDH1 mutation 63 erythropoiesis 63 Fig. 1D 63 β blocker 63 methotrexate monotherapy 63 integrin alpha 63 posttreatment 63 factor HGF 63 Fibroblast Growth Factor Receptor 63 Cyclophosphamide 63 Triapine R 63 agonist LABA 63 flutamide 63 APOPTONE 63 HMG CoA reductase inhibitor 63 angiotensin converting enzyme inhibitors 63 interferon beta 63 serum creatinine levels 63 liposomal doxorubicin 63 ERBB2 63 immunomodulatory therapy 63 Phase Ib clinical 63 downregulation 63 Ocrelizumab 63 cyclooxygenase COX 63 XOMA 3AB 63 HCV replication 63 FGFR3 63 interferon ribavirin 63 ciclesonide 63 Taxol ® 63 Hazard Ratio